Babies' Brain Responses to Strangers

March 3, 2025 updated by: University of California Santa Cruz

The Malleability of Social Group Understanding in Infancy and Early Childhood

Researchers at the Diversity in Development Lab at UC Santa Cruz are investigating how babies' brain activities respond to people from familiar and unfamiliar racial backgrounds.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The goal of this observational study is to learn how infants' brain activities, as captured by EEG, differ for familiar or unfamiliar racial group in typically developing infants. The main questions of the study are:

  • Will infants show greater event-related desynchronization (i.e., more motor system activation), frontal theta synchronization (i.e., more attention), and more positive frontal alpha asymmetry (i.e., more approach motivation) to familiar than unfamiliar racial group?
  • How does infants' exposure to racial diversity in their social network and neighborhoods relate to these EEG activities? Participants will visit a laboratory at the UC Santa Cruz campus for this study. Infants will put an EEG cap on and watch about 15 minutes of videos, in which people from different racial backgrounds do different actions (e.g., grabbing an object, saying hi and approaching closer, and playing peek-a-boo). Caregivers will be asked to fill out a demographic form and a social network survey.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Santa Cruz, California, United States, 95064
        • Recruiting
        • Social Science 2 Building
        • Contact:
        • Contact:
          • Hyesung Hwang, PhD
        • Contact:
          • Samantha Fong, BA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

community sample from the larger Santa Cruz area

Description

Inclusion Criteria:

  • typically developing
  • age 7 to 12 months
  • at least 37 weeks gestation

Exclusion Criteria:

  • any known developmental delays
  • less than 37 weeks gestation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mu event related desynchronization
Time Frame: Through study completion, an average of 10 years.
EEG oscillation in alpha power over central regions
Through study completion, an average of 10 years.
Frontal theta synchronization
Time Frame: Through study completion, an average of 10 years.
EEG oscillation in theta power over frontal regions
Through study completion, an average of 10 years.
Frontal alpha asymmetry
Time Frame: Through study completion, an average of 10 years.
left and right hemispheric difference in EEG oscillation in alpha power in the frontal regions
Through study completion, an average of 10 years.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hyesung Hwang, PhD, University of California Santa Cruz

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 23, 2024

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

October 1, 2025

Study Registration Dates

First Submitted

August 6, 2024

First Submitted That Met QC Criteria

August 9, 2024

First Posted (Actual)

August 13, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 3, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HS-FY2023-23 Study 2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that are anonymized and underlie results in a publication will be shared through open science framework (OSF)

IPD Sharing Time Frame

The data will become available within a period of 10 years. Anonymized aggregate data will be available indefinitely. No identifiable data will be shared.

IPD Sharing Access Criteria

All anonymized data will be available once study has been published and will be available indefinitely.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant Development

Subscribe